🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Chronic and Episodic Headache

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine NCT07159750n/a26 sites📍 Miami📍 Buenos Aires📍 Santiago Hospital Universitari Vall d'Hebron Research Institute · Tests: CGRP antibody or gepant Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine NCT07279623NA1 site📍 Stockholm Abilion Medical Systems AB · Tests: INMEST-treatment i-NEED: NEw migrainE Drugs Database NCT07103694n/a2 sites📍 Milan📍 Rome IRCCS San Raffaele Roma · Tests: anti-CGRP monoclonal antibodies, gepants, combination of sumatriptan and naproxen, ditan A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine NCT07719608NA3 sites📍 Newnan📍 Olney📍 Charlotte Salvia BioElectronics · Tests: Neurostimulator Study of EVO756 in Adults With Migraine NCT07616128Phase 235 sites📍 Chandler📍 Buena Park📍 Fresno Evommune, Inc. · Tests: EVO756, Dose 1, EVO756, Dose 2, Placebo Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD NCT07348783NA1 site📍 Huddinge Karolinska Institutet · Tests: Intervention yoga based exercises PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE NCT07268768n/a1 site📍 Messina IRCCS Centro Neurolesi Bonino Pulejo · Tests: Neuropsychological assessment Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification NCT06674772n/a1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: Saliva test EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine. NCT05570149n/a1 site📍 Roma IRCCS San Raffaele Roma · Tests: Eptinezumab 100 mg or Eptinezumab 300 mg administered intravenously in 100 mL saline solution A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine NCT05164172Phase 364 sites📍 New Haven📍 Stamford📍 Gainesville H. Lundbeck A/S · Tests: Eptinezumab Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine NCT06603558n/a36 sites📍 Busan📍 Busan📍 Busan AbbVie · Tests: Atogepant CGRP Inhibition, Autonomic Function, and Migraine NCT04628429n/a1 site📍 Vienna Medical University of Vienna · Tests: Erenumab, Galcanezumab, Fremanezumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy